PHARMACEUTICAL USE OF HEXAHYDRO-DIBENZO[A,G]QUINOLIZINE COMPOUNDS
申请人:Shanghai Institute of Materia Medica,
Chinese Academy of Sciences
公开号:EP2992883A1
公开(公告)日:2016-03-09
Use of hexahydro-dibenzo[a,g]quinolizine compounds as shown in formula(I) in preparing a medicine for treating and/or preventing benign prostate hyperplasia diseases.